ProShare Advisors’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-7,391
| Closed | -$793K | – | 1945 |
|
|
2023
Q1 | $793K | Sell |
7,391
-555
| -7% | -$59.6K | ﹤0.01% | 771 |
|
|
2022
Q4 | $874K | Buy |
7,946
+1,132
| +17% | +$125K | ﹤0.01% | 768 |
|
|
2022
Q3 | $402K | Buy |
+6,814
| New | +$402K | ﹤0.01% | 991 |
|
|
2022
Q2 | – | Sell |
-9,650
| Closed | -$365K | – | 2230 |
|
|
2022
Q1 | $365K | Sell |
9,650
-2,318
| -19% | -$87.7K | ﹤0.01% | 1499 |
|
|
2021
Q4 | $474K | Buy |
+11,968
| New | +$474K | ﹤0.01% | 1490 |
|